局部与全身氨甲环酸减少全膝关节置换术和全髋关节置换术后失血的比较:系统综述与Meta分析
该系统综述与Meta分析纳入59项随机对照试验共6791例择期全膝关节置换术(TKA)和全髋关节置换术(THA)患者,比较局部与全身氨甲环酸(TXA)减少失血的效果。合并分析显示两组总失血量无显著差异(Hedges g=0.11;95%CI -0.04至0.26;I²=82.4%),但亚组分析显示TKA中局部TXA较全身TXA显著减少总失血量(g=0.19;95%CI 0.00至0.38;I²=85%;p=0.046),THA中则相反。
要点
- 合并TKA与THA分析,局部与全身TXA在总失血量上无显著差异(g=0.11;95%CI -0.04至0.26)。
- TKA患者中局部TXA较全身TXA显著减少总失血量(g=0.19;95%CI 0.00至0.38;p=0.046)。
- THA患者中全身TXA较局部TXA显著减少总失血量,与TKA结果相反。
核心结论
- 在TKA与THA合并分析中,局部与全身TXA减少失血的效果相当。
- 在TKA中,局部应用TXA较全身应用显著减少失血量;在THA中则相反。
- 仍需进一步研究以确定最佳TXA剂量和给药途径。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Embase和Cochrane CENTRAL数据库。
- 纳入比较局部与全身TXA用于择期TKA和THA患者的随机对照试验。
- 共纳入59项随机对照试验,合计6791例患者。
- 主要结局为手术总失血量;次要结局为术后输血需求、血红蛋白下降、住院时间和主要不良事件(感染和血栓栓塞事件)频率。
- 采用RStudio进行数据合并,并行TKA与THA亚组分析。
主要发现
- 局部与全身TXA在总失血量上无显著差异(Hedges g=0.11;95%CI -0.04至0.26;I²=82.4%)。
- 两组在血红蛋白下降、住院时间和输血需求方面也无显著差异。
- TKA亚组中,局部TXA组较全身TXA组总失血量显著减少(g=0.19;95%CI 0.00至0.38;I²=85%;p=0.046)。
- THA亚组中,全身TXA较局部TXA显著减少总失血量,与TKA结果相反。
关键数值与推荐
- 主要结局总失血量:Hedges g=0.11;95%CI -0.04至0.26;I²=82.4%。
- TKA亚组总失血量:g=0.19;95%CI 0.00至0.38;I²=85%;p=0.046。
- 证据等级:治疗性I级。
临床怎么用
- 原文未据此给出推荐。
局限性
- 仍需进一步研究以确定最佳TXA剂量和给药途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tranexamic acid (TXA) has been shown to reduce blood loss during total knee arthroplasty (TKA) and total hip arthroplasty (THA), but the most effective administration method has yet to be determined. This systematic review and meta-analysis aimed to compare topical and systemic TXA administration to reduce operative blood loss. METHODS: MEDLINE, Embase, and Cochrane CENTRAL were screened for randomized controlled trials comparing topical and systemic TXA for patients who underwent elective TKA and THA. The primary outcome was the total volume of operative blood loss, and the secondary outcomes were postoperative transfusion requirements, hemoglobin drop, hospital length of stay, and the frequencies of the main adverse events (infections and thromboembolic events). Data pooling was performed using RStudio. Subgroup analyses compared outcomes between TKA and THA. RESULTS: Fifty-nine randomized controlled trials with a total of 6,791 patients were included in this review. Data analysis showed no significant difference between topical and systemic TXA application in terms of total blood loss (Hedges g = 0.11; 95% confidence interval [CI], -0.04 to 0.26; I 2 = 82.4%). There was also no significant difference between the 2 groups in hemoglobin drop, hospital length of stay, and transfusion requirements. Subgroup analysis showed that patients undergoing TKA who received topical TXA had a significant reduction in total blood loss (g = 0.19; 95% CI, 0.00 to 0.38; I 2 = 85%; p = 0.046) compared with those who received systemic TXA. CONCLUSIONS: Topical and systemic TXA were equally effective in reducing blood loss in the analysis in which THA and TKA were combined. However, in TKA, topical application significantly reduced blood loss compared with systemic administration, while the reverse was true in THA. Further research is still necessary to find the optimal TXA dosage and administration route. LEVEL OF EVIDENCE: Therapeutic Level I . See Instructions for Authors for a complete description of levels of evidence.
引用
- Boucher M, Tremblay J, Pelet T, et al. Topical Versus Systemic Tranexamic Acid to Reduce Blood Loss After Total Knee and Total Hip Arthroplasty: A Systematic Review and Meta-Analysis. J Bone Joint Surg Am. 2025. PMID: 40763214. doi:10.2106/JBJS.24.01511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。